Biotech

All Articles

Navigator increases $100M to cultivate brand-new autoimmune pipeline

.Sat nav Medicines has outfitted itself with $one hundred million in series A funds as the youthful ...

Duality looks for cash for ADC trials as IPO wave infects Asia

.China's Duality Biotherapeutics has actually filed (PDF) documents for a Hong Kong IPO, seeking a s...

YolTech sells China liberties to gene modifying therapy for $29M

.Four months after Mandarin genetics editing provider YolTech Therapeutics took its cholesterol dise...

Addex sell climbs after Indivior offers up to $300M for material

.Indivior is grabbing a small molecule allosteric modulator created to manage element use condition ...

Molecular Partners fine-tunes AML test over 'suboptimal exposure'

.Molecular Companions has actually determined "suboptimal visibility" to its own tetra-specific T-ce...

Despite blended market, a financial backing rebirth could be being available in Europe: PitchBook

.While the biotech financial investment performance in Europe has decreased somewhat complying with ...

8 months after a $213M fundraise, genetics publisher Tome makes cuts

.After increasing $213 thousand in 2023-- one of the year's largest exclusive biotech rounds-- Tome ...

BioMarin constructs director team along with biotech vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable management hirings, firings and also ...

Biopharma Q2 VC attacked highest degree due to the fact that '22, while M&ampA reduced

.Equity capital backing right into biopharma rose to $9.2 billion around 215 sell the 2nd fourth of ...

Bicara, Zenas find IPOs to push late-phase assets toward market

.Bicara Therapeutics as well as Zenas Biopharma have actually offered new motivation to the IPO mark...